Physician
University of Texas Southwestern Medical Center at Dallas
University of Texas Southwestern Medical Center at Dallas was paid $2.55M by Medicaid between Jan 2018 and Dec 2024, across 106 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 53% of everything it billed.
33Billing provider infoUNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS
DALLAS, TX 75390
DALLAS, TX 75390
33aNPI1104891050assigned 02/22/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.55M
24GClaims132,077
24DCodes billed106
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Texas
Rank by total paid#3 of 97
Median peer was paid$24K
This provider vs. median108×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MEYER, BRUCE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,335 | $27K | |
| 2019 | 1,481 | $31K | |
| 2020 | 5,423 | $121K | |
| 2021 | 29,481 | $629K | |
| 2022 | 48,260 | $706K | |
| 2023 | 31,062 | $600K | |
| 2024incomplete | 15,035 | $437K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 53% | 18,896 | 18,191 | $1.36M |
| 88307 | 19% | 8,895 | 8,367 | $489K | |
| 88141 | 3.3% | 5,855 | 5,497 | $85K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.5% | 2,445 | 2,318 | $64K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.5% | 2,443 | 2,316 | $64K |
| 88108 | 2.4% | 3,750 | 3,285 | $61K | |
| 88304 | 2.0% | 5,387 | 5,249 | $50K | |
| 88342 | 1.6% | 1,180 | 1,134 | $40K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.2% | 3,775 | 2,682 | $31K |
| 86780 | 1.1% | 3,739 | 2,617 | $28K | |
| 88302 | 1.0% | 5,373 | 4,966 | $27K | |
| 80050 | General health panel | <1% | 1,077 | 784 | $21K |
94 more codes
| 88112 | <1% | 1,029 | $20K | |
| 80500 | <1% | 1,316 | $14K | |
| 85027 | <1% | 3,796 | $14K | |
| 86762 | <1% | 1,234 | $13K | |
| 86850 | <1% | 1,918 | $13K | |
| 87088 | <1% | 2,160 | $12K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 647 | $12K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,041 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 4,524 | $11K |
| 87340 | <1% | 1,884 | $11K | |
| 86803 | <1% | 948 | $7K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,560 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,141 | $7K |
| 88350 | <1% | 50 | $6K | |
| 87081 | <1% | 1,247 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 814 | $4K |
| 87799 | <1% | 372 | $4K | |
| 86901 | <1% | 1,778 | $4K | |
| 86900 | <1% | 1,777 | $4K | |
| 82728 | <1% | 853 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 623 | $4K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 89 | $3K |
| 80061 | Lipid panel | <1% | 637 | $3K |
| 88341 | <1% | 52 | $3K | |
| G0452 | Molecular pathology procedure; physician interpretation and report | <1% | 142 | $3K |
| 80197 | <1% | 705 | $2K | |
| 82950 | <1% | 1,231 | $2K | |
| 88348 | <1% | 38 | $2K | |
| 88346 | <1% | 49 | $2K | |
| 87077 | <1% | 666 | $2K | |
| 87497 | <1% | 157 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 76 | $2K |
| 83540 | <1% | 539 | $2K | |
| 83735 | <1% | 3,010 | $1K | |
| 83550 | <1% | 425 | $1K | |
| 88313 | <1% | 50 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,224 | $1K |
| 36512 | <1% | 13 | $1K | |
| 84165 | <1% | 685 | $942.10 | |
| 84439 | <1% | 335 | $913.06 | |
| 80069 | <1% | 1,387 | $907.38 | |
| 82977 | <1% | 1,130 | $806.60 | |
| 82803 | <1% | 1,580 | $715.04 | |
| 84100 | <1% | 2,122 | $673.60 | |
| 83880 | <1% | 149 | $655.68 | |
| 82330 | <1% | 777 | $653.13 | |
| 88311 | <1% | 52 | $568.48 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 19 | $550.00 |
| 83020 | <1% | 103 | $498.88 | |
| 86140 | <1% | 1,077 | $458.08 | |
| 82570 | <1% | 233 | $446.13 | |
| 82610 | <1% | 152 | $399.82 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13 | $336.53 |
| 84156 | <1% | 242 | $327.20 | |
| 81001 | <1% | 511 | $311.22 | |
| 80076 | <1% | 359 | $306.16 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 788 | $249.38 |
| 84702 | <1% | 17 | $199.51 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 19 | $175.00 |
| 86255 | <1% | 129 | $173.16 | |
| 82248 | <1% | 677 | $127.86 | |
| 84132 | <1% | 403 | $125.00 | |
| 81003 | <1% | 770 | $113.29 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 38 | $111.00 |
| 83615 | <1% | 108 | $97.44 | |
| 84460 | <1% | 450 | $89.84 | |
| 87070 | <1% | 483 | $81.45 | |
| 84145 | <1% | 346 | $69.00 | |
| 85610 | <1% | 588 | $68.34 | |
| 87040 | <1% | 348 | $65.04 | |
| 86334 | <1% | 25 | $59.67 | |
| 84520 | <1% | 149 | $41.50 | |
| 85730 | <1% | 104 | $37.87 | |
| 84450 | <1% | 127 | $27.20 | |
| 82947 | <1% | 47 | $25.80 | |
| 82565 | <1% | 108 | $20.44 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $14.50 |
| 82948 | <1% | 89 | $10.58 | |
| 85045 | <1% | 123 | $8.38 | |
| 82247 | <1% | 96 | $5.28 | |
| 85652 | 0% | 58 | $0.00 | |
| 87428 | 0% | 46 | $0.00 | |
| 83690 | 0% | 14 | $0.00 | |
| 0099U | 0% | 23 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 22 | $0.00 |
| 84703 | 0% | 16 | $0.00 | |
| 81511 | 0% | 14 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 72 | $0.00 |
| 80235 | 0% | 79 | $0.00 | |
| 85014 | 0% | 40 | $0.00 | |
| 83970 | 0% | 34 | $0.00 | |
| 84295 | 0% | 20 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 25 | $0.00 |
| 81025 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMEYER, BRUCE (EXECUTIVE VICE PRESIDENT)
Parent organizationUNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.